miRNA-21 as Reliable Serum Diagnostic Biomarker Candidate for Metastatic Progressive Prostate Cancer: Meta-analysis Approach

BACKGROUND: Prostate cancer is the second leading cause of cancer death in men, moreover when it develops metastasis. However, PSA detection in serum as current gold standard to measure disease progressivity had wide variability leading to confounding outcomes. MicroRNA-21 has diagnostic values for...

Descripción completa

Detalles Bibliográficos
Autores principales: Seputra, Kurnia Penta, Purnomo, Basuki Bambang, Susianti, Hani, Kalim, Handono, Purnomo, Athaya Febriantyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740671/
https://www.ncbi.nlm.nih.gov/pubmed/35169355
http://dx.doi.org/10.5455/medarh.2021.75.347-350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740671/
https://www.ncbi.nlm.nih.gov/pubmed/35169355
http://dx.doi.org/10.5455/medarh.2021.75.347-350

Ejemplares similares